309 related articles for article (PubMed ID: 17259232)
21. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
Keskin G; Inal A; Keskin D; Pekel A; Baysal O; Dizer U; Sengül A
Protein Pept Lett; 2008; 15(3):314-7. PubMed ID: 18336364
[TBL] [Abstract][Full Text] [Related]
22. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
[TBL] [Abstract][Full Text] [Related]
23. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
Debaugnies F; Servais G; Badot V; Noubouossie D; Willems D; Corazza F
Scand J Rheumatol; 2013; 42(2):108-14. PubMed ID: 23126558
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
25. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies.
Webb T; Lakos G; Swart A; Gürtler I; Favalli EG; Schioppo T; Mahler M
Clin Chim Acta; 2014 Nov; 437():161-7. PubMed ID: 25086283
[TBL] [Abstract][Full Text] [Related]
27. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
Front Immunol; 2018; 9():1113. PubMed ID: 29928272
[TBL] [Abstract][Full Text] [Related]
29. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.
Vander Cruyssen B; Cantaert T; Nogueira L; Clavel C; De Rycke L; Dendoven A; Sebag M; Deforce D; Vincent C; Elewaut D; Serre G; De Keyser F
Arthritis Res Ther; 2006; 8(4):R122. PubMed ID: 16859515
[TBL] [Abstract][Full Text] [Related]
31. A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist's office.
Zandman-Goddard G; Soriano A; Gilburd B; Lidar M; Kivity S; Kopilov R; Langevitz P; Shoenfeld Y; Agmon-Levin N
Immunol Res; 2017 Feb; 65(1):363-368. PubMed ID: 27470303
[TBL] [Abstract][Full Text] [Related]
32. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
33. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
34. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
36. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis.
Vincent C; Nogueira L; Sebbag M; Chapuy-Regaud S; Arnaud M; Letourneur O; Rolland D; Fournié B; Cantagrel A; Jolivet M; Serre G
Arthritis Rheum; 2002 Aug; 46(8):2051-8. PubMed ID: 12209508
[TBL] [Abstract][Full Text] [Related]
37. Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.
Sghiri R; Bouajina E; Bargaoui D; Harzallah L; Fredj HB; Sammoud S; Ghedira I
Rheumatol Int; 2008 Nov; 29(1):59-62. PubMed ID: 18496693
[TBL] [Abstract][Full Text] [Related]
38. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
[TBL] [Abstract][Full Text] [Related]
39. Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.
Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Houen G
PLoS One; 2016; 11(12):e0168542. PubMed ID: 28002483
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.
Sanmartí R; Graell E; Perez ML; Ercilla G; Viñas O; Gómez-Puerta JA; Gratacós J; Balsa A; Gómara MJ; Larrosa M; Cañete JD; Haro I
Arthritis Res Ther; 2009; 11(5):R135. PubMed ID: 19725967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]